Search for Clinical Trial Results

Sponsored By

Choroiditis - 31 Studies Found

Status Study
Completed Study Name: Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Condition:
  • Vogt Koyanagi Harada Disease
  • Serpiginous Choroiditis
  • Date: 2006-12-01
    Interventions:
    • Drug: Bevacizumab
    • Procedure: Intravitreal

Completed Study Name: Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
Condition:
  • Neovascularization
  • Tuberculosis
  • Multifocal Serpiginous Date: 2008-03-25
Completed Study Name: Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Condition:
  • Choroiditis
  • Iridocyclitis
  • Iri
    Date: 2000-08-26
Withdrawn Study Name: Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Condition:
  • Choroidal Neovascularization
  • Myopia
  • Punctate Inner Choroid
    Date: 2010-10-29
    Interventions:
    • Drug: Bevacizumab (Avastin; Genentech, Inc.)

Completed Study Name: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Condition:
  • Coats' Disease
  • Idiopathic Retinal Telangiectasia
  • Retinal A
    Date: 2007-05-04
    Interventions: Drug: ranibizumab injection (0.5 mg) ranibizumab 10mg mg/ml. , 0.3ml/vial, 0.05 ml./injection intravitre
Not yet recruiting Study Name: Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Condition:
  • Uveitis
  • Uveitis, Posterior
  • Uveitis, Anterior
  • Date: 2017-03-27
    Interventions: Combination Product: 4mg CLS-TA Suprachoriodal Injection CLS-TA, 4 mg in 100 microliters, will be admini
Recruiting Study Name: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Condition:
  • Uveitis
  • Uveitis, Posterior
  • Uveitis, Anterior
  • Date: 2016-10-31
Active, not recruiting Study Name: A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Condition:
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
    • Date: 2016-04-19
    Interventions: Drug: FAI insert
Active, not recruiting Study Name: Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis
Condition:
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
    • Date: 2016-04-19
    Interventions:
    • Drug: Sham Injection
    • Drug: FAI Insert
Completed Study Name: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Condition:
  • Uveitis
  • Intermediate Uveitis
  • Posterior Uveitis
  • Date: 2013-02-05
    Interventions: Drug: triamcinolone acetonide (Triesence®) 4 mg of TRIESENCE® (triamcinolone acetonide injecta
Next >>>